«There are clearly molecular differences between African - American and Caucasian
multiple myeloma
cases, and it will be critical to pursue these observations to better improve clinical management of the disease for all patients,» said John D. Carpten, senior
author of the
study and chair of the Department of Translational Genomics at the Keck School of Medicine.